General News - June 14, 2026 at 12:30 PM

Top of Mind
SpaceX (SPCX) closed its first day up ~19% to $160.95, a $2.1T market cap — the largest IPO ever. Retail bought $118M on day one, a record. The successful debut steadied broader markets after a volatile week and revived appetite for riskier tech bets. However, the “index arbitrage” trade is now crowded; the pop likely already prices in index fund buying, and the green-shoe option can cap further gains. The bigger macro story is the Iran deal: Trump says signing Sunday, but Iran pushes back on timing. If the Strait of Hormuz reopens, oil (CL1) could fall further (down ~6% this week), which would be a tailwind for equities and bonds but a headwind for energy equities and the ruble. We are short-dated long SPY via call spreads going into Sunday night; if the deal fails, hedged with puts on energy (XLE).

Catalyst Radar

• Mon: China retail/industrial production data; G7 summit begins in Évian; Trump expected to attend.
• Tue: US housing starts; Fed begins 2-day meeting.
• Wed: Fed decision (widely expected hold, but watch Warsh’s debut presser).
• Thu: BOE decision (expected hold); US retail sales.
• Fri: Triple witching (OpEx); MSCI Korea classification review (June 23).

Markets

• S&P 500 (+1.5%) and Nasdaq (+2.1%) rallied Friday, led by semis (NVDA, AMD) and banks (JPM, GS). Spacex IPO absorbed well — $522M shares traded on float of 556M, heavy retail participation.
• Treasury yields fell for the week (10yr -5.2bp to 4.485%, 2yr -7.7bp to 4.083%) on Hormuz reopening hopes. Bund yields range-bound (2.90-3.10%).
• Oil (WTI) fell ~6% on deal optimism; but backwardation in the curve suggests traders still expect tight supply even if strait reopens, given ~500M barrels of inventory drawdown and slow rebuilding.
• Asian currencies remain under pressure (KRW -5% YTD) despite AI export boom — Koreans are selling domestic stocks to buy US tech, and foreign investors are booking gains.
• CLO ETFs see record inflows ($9B YTD) as investors chase high yields and avoid private credit (BlackRock HPS fund had 13% redemption requests, will only repurchase 5%).
• Singapore Exchange DAV surged 79% YoY in May — haven inflows from Middle East conflict.

Economy

• New York Fed shows 90+ day credit card delinquencies 13%, near ’08 highs, but total debt service ratio is low (5.4% of disposable income) and charge-offs (3.8%) are below long-term average. Not a systemic signal.
• Fed hold this week is a lock; the risk is that persistent oil-driven inflation forces a hawkish tilt. The ECB hiked 25bp (first since 2023) on energy price pressures.
• Swiss voters appear set to reject the 10M population cap (55% “no”), avoiding a rupture with EU on free movement. Business relief (Nestle, Roche, UBS).

Business/Finance

• BlackRock HPS Corporate Lending Fund saw 13% redemption requests, up from 9.3%. Fund will only meet 5%, leaving investors stuck. Contrast with CLO ETFs.
• NextEra Energy (NEE) down 9% since Dominion deal announcement — but the merger rationale is solid (exposure to Virginia data-center growth, higher regulated mix). Termination fee ($4.8B) is less than market cap lost. Good risk/reward for long-term.
• Citigroup launches tokenized depository receipts for private company shares on blockchain (SIX). Wealthy clients can now hold private equity alongside public stock. Early focus on foreign investors.
• Wise (WISE) transfers primary listing to Nasdaq; Berenberg sees more market share gains.
• Corning (GLW) continues to win massive fiber deals (NVDA, META, AMZN) with risk-sharing provisions — CEO insists customers put up upfront capex. Stock doubled YTD.
• Adyen (ADYEN) acquires Orb for $335M to compete with Stripe in metered billing. Stock up 4.7% but still down 40% YTD.

World/Geopolitics

• US-Iran deal timeline uncertain. Trump says signed Sunday; Iran says “not tomorrow.” Pakistan mediating. A senior admin official puts odds at 80-85%. Key condition: removal of enriched uranium. UK and France would lead mine-clearing in Hormuz.
• UAE denies reports it released frozen Iranian funds — says false. Critical for oil markets if true.
• UK forces board sanctioned Russian “shadow fleet” tanker in English Channel — first such operation. Shows increased enforcement against Russian oil trade.
• Mongolia reaffirms One China policy with Foreign Minister Wang Yi — bilateral trade expected $20B this year. Important for rare earths (REE) supply stability.
• G7 summit in Évian likely to be tense: AI regulation vs. US laissez-faire, NATO burden-sharing, Ukraine aid. Macron invited Sam Altman.

Technology/AI

• Anthropic disables Fable 5 and Mythos 5 models worldwide per US government export controls — cites “national security authorities.” Rare move; highlights AI as a geopolitical asset. Litigation ongoing.
• Meta (META) down 18% YoY despite 33% revenue growth. Subscription push ($4/month for features) seen as inadequate vs. AI capex (50% of revenue). Analysts skeptical of $15-20B subscription revenue forecasts. Meta still 98% ad dependent.
• Musk’s history with Google’s Larry Page: SpaceX now has $30B AI infrastructure lease with Google (roughly $920M/month for 32 months). Despite personal rift, business ties deepen.
• Corning’s CEO says data-center fiber sales will soon eclipse telco: “every GPU needs to talk to every other GPU.” Optical is the bottleneck.
• Rivian CEO starts Mind Robotics (humanoid robots) separate from Rivian — raised >$1B. First product in <1 year; Rivian is minority owner and launch customer. Contrast with Musk’s Tesla integration.

Standouts

1. Ken Leech (ex-Western Asset) pleads guilty to obstructing SEC probe; original fraud charges dropped — avoids 20-year max but faces 5 years.
2. Polymarket “clarifications” wipe out $35K in student’s winning bet on Strategy (MSTR) bitcoin sale — highlights settlement risk in prediction markets.
3. CLO ETFs attracting record inflows as private credit redemptions spike (BlackRock, Blackstone, Cliffwater). Higher-quality, liquid structure preferred.
4. SpaceX employees with >$1B in combined assets negotiate 0.5% wealth management fee with Choreo — below industry standard. Engineers want group whiteboarding for financial planning.
5. Obesity drug race: Lilly’s retatrutide shows best weight loss yet at ADA, while Zealand Pharma’s amylin analogue shows fewer side effects. Pfizer/Amgen targeting monthly or quarterly dosing.